sellWeak
Justin Burgess sold $262k of DVAX
Chief Accounting Officer at DYNAVAX TECHNOLOGIES CORP. 20,526 shares at an average of $12.78, traded Mar 1, 2024, filed Mar 4, 2024.
Warning score
33Value
$262k
20,526 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +13Trade size$262k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-024970, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2024 | MOption exercise Common Stock | +4,334 | $11.12 | $48k | 17,759 | Mar 4, 2024 |
| Mar 1, 2024 | MOption exercise Common Stock | +2,767 | $9.41 | $26k | 20,526 | Mar 4, 2024 |
| Mar 1, 2024 | SOpen-market sale Common Stock | -7,101 | $12.78 | $91k | 13,425 | Mar 4, 2024 |
| Mar 1, 2024 | SOpen-market sale Common Stock | -13,425 | $12.78 | $172k | 0 | Mar 4, 2024 |
| Mar 1, 2024 | MOption exercise Stock Options (Right to Buy)derivative | -4,334 | $0.00 | $0 | 8,666 | Mar 4, 2024 |
| Mar 1, 2024 | MOption exercise StockOptions (Right to Buy)derivative | -2,767 | $0.00 | $0 | 0 | Mar 4, 2024 |
Related signals
Other insiders at DYNAVAX TECHNOLOGIES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $1.8M 114,000 shares | -64% | |
| 7Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $465k 30,000 shares | -21% | |
| 24Weak | DVAXbuy DYNAVAX TECHNOLOGIES CORP | Scott Dunseth Myers director | $41k 3,800 shares | +12% | |
| 42Moderate | DVAXsell DYNAVAX TECHNOLOGIES CORP | Deep Track Biotechnology Master Fund, Ltd. owner | $22M 2,065,137 shares | -12% | |
| 16Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $140k 10,000 shares | -55% | |
| 32Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $190k 14,020 shares | -63% | |
| 37Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $471k 32,764 shares | -60% | |
| 21Weak | DVAXsell DYNAVAX TECHNOLOGIES CORP | Francis Cano director | $43k 3,615 shares | -9% | |
| 0Weak | DYNAVAX TECHNOLOGIES CORP | Robert Janssen SVP and CMO | $23k 1,500 shares | -3% | |
| 24Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $130k 9,000 shares | -74% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.